Chi-Hsiang Wu

Papers

Total Citations

H-Index

About

Dr. Chi-Hsiang Wu is a pioneering urologic surgeon and researcher whose work centers on advancing precision oncology for prostate cancer through innovative surgical technologies and risk-stratified treatment strategies. His major contributions lie at the intersection of robotic-assisted surgery and augmented reality, most notably demonstrated in the first-ever case report of VR-RENDER Fusion Software integration during robot-assisted partial prostatectomy (2023). This landmark study, which has garnered early citations for its novelty, introduces a paradigm shift by enabling real-time, three-dimensional tumor visualization during surgery, thereby preserving healthy tissue while ensuring oncologic control. Dr. Wu’s research addresses the critical clinical dilemma of overtreatment in favorable intermediate-risk prostate cancer, advocating for focal therapy as a middle ground between active surveillance and radical prostatectomy. His work has significant implications for reducing functional morbidity—such as incontinence and erectile dysfunction—without compromising cancer outcomes. By merging cutting-edge software with surgical robotics, Dr. Wu is redefining the standard of care for localized prostate cancer, offering patients a more personalized, less invasive path to treatment. His contributions are poised to influence both urologic oncology practice and the broader field of image-guided surgery.